TruBridge Market Cap

TruBridge has a market cap or net worth of $123.75 million as of May 3, 2024. Its market cap has decreased by -67.50% in one year.

Market Cap

123.75M

Enterprise Value

316.81M

1-Year Change

-67.50%

Ranking

#3977

Market Cap Chart

Since May 21, 2002, TruBridge's market cap has decreased from $190.00M to $123.75M, a decrease of -34.87%. That is a compound annual growth rate of -1.93%.

Market Cap History

Date	Market Cap	% Change
May 2, 2024	123.50M	5.65%
May 1, 2024	116.90M	2.01%
Apr 30, 2024	114.60M	-5.13%
Apr 29, 2024	120.80M	3.60%
Apr 26, 2024	116.60M	2.37%
Apr 25, 2024	113.90M	-0.87%
Apr 24, 2024	114.90M	-2.13%
Apr 23, 2024	117.40M	-1.76%
Apr 22, 2024	119.50M	-0.42%
Apr 19, 2024	120.00M	2.13%
Apr 18, 2024	117.50M	-2.57%
Apr 17, 2024	120.60M	-0.41%
Apr 16, 2024	121.10M	-2.34%
Apr 15, 2024	124.00M	-2.75%
Apr 12, 2024	127.50M	-1.92%
Apr 11, 2024	130.00M	-0.54%
Apr 10, 2024	130.70M	-1.13%
Apr 9, 2024	132.20M	0.76%
Apr 8, 2024	131.20M	1.94%
Apr 5, 2024	128.70M	6.63%
Apr 4, 2024	120.70M	-2.03%
Apr 3, 2024	123.20M	-3.30%
Apr 2, 2024	127.40M	4.26%
Apr 1, 2024	122.20M	-8.67%
Mar 28, 2024	133.80M	-3.53%

View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AEON Biopharma	128.08M
Coya Therapeutics	127.68M
Citius Pharmaceuticals	127.63M
Karyopharm Therapeutics	125.78M
Molecular Partners AG	123.70M
Nuvectis Pharma	120.12M
Vor Biopharma	120.06M
Immunic	119.61M

Market Cap Rankings